WELL Health Technologies (TSE:WELL) Hits New 12-Month High on Analyst Upgrade

WELL Health Technologies Corp. (TSE:WELL - Get Free Report) reached a new 52-week high during mid-day trading on Monday after Scotiabank raised their price target on the stock from C$6.00 to C$7.00. The company traded as high as C$7.05 and last traded at C$7.02, with a volume of 967704 shares changing hands. The stock had previously closed at C$6.79.

Several other analysts have also issued reports on WELL. Ventum Financial dropped their price target on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating on the stock in a research report on Tuesday, October 29th. Haywood Securities upped their target price on shares of WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday. Finally, CIBC lifted their price target on WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday.

WELL Health Technologies Stock Up 2.9 %

The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57. The stock has a market cap of C$1.74 billion, a P/E ratio of 12.33, a PEG ratio of -1.93 and a beta of 1.20. The firm has a 50-day simple moving average of C$5.14 and a two-hundred day simple moving average of C$4.69.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.